# Ketamine Versus Dexmedetomidine for Prevention of Postoperative Delirium

> **NCT05341154** · NA · COMPLETED · sponsor: **Huda Fahmy Mahmoud, PhD** · enrollment: 60 (actual)

## Conditions studied

- Emergence Delirium

## Interventions

- **DRUG:** Ketamine Hcl 50Mg/Ml Inj

## Key facts

- **NCT ID:** NCT05341154
- **Lead sponsor:** Huda Fahmy Mahmoud, PhD
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-01
- **Primary completion:** 2023-05-06
- **Final completion:** 2023-05-06
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2023-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05341154

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05341154, "Ketamine Versus Dexmedetomidine for Prevention of Postoperative Delirium". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05341154. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*